Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Cranial Nerve Diseases

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cranial Nerve Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akagi, N; Fujiwara, M; Fukumoto, M; Kurohara, A; Miyazaki, N; Ogawa, Y; Osaki, Y; Yoshida, D; Yoshida, S1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cranial Nerve Diseases

ArticleYear
Dual-isotope SPECT diagnosis of a skull-base metastasis causing isolated unilateral hypoglossal nerve palsy.
    Annals of nuclear medicine, 1998, Volume: 12, Issue:4

    Topics: Cranial Nerve Diseases; Female; Humans; Hypoglossal Nerve; Middle Aged; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

1998